Drugs / N332-GT5 gp140
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06033209 | Nov 2023 → Dec 2025 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N332-GT5 gp140 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06033209 ↗ |
| Modality | Protein / enzyme biologic | “N332-GT5 gp140 HIV trimer protein” NCT06033209 ↗ |
| Route | Intramuscular | “IM in the deltoid” NCT06033209 ↗ |